CeVi collection of viable cells

Strengthen efficacy and safety evidence using relevant preclinical models and translational data.

Scientific visual associated with CeVi collection of viable cells
Biomarkers expertise — CALYM
01Carnot instituteCALYM
02Development stagePreclinical validation
03Main expertiseBiomarkers
04Relevant fieldsOncology

Offer overview

What this offer helps you achieve

Strengthen efficacy and safety evidence using relevant preclinical models and translational data.

Scientific and technical scope

Eight Biological Resource Centres pool cryopreserved viable human cells from lymphomas, myeloma, CLL and reactive lymphoid tissues. The collection provides biological material annotated with clinical and biological data from more than 3,500 patients (28,000 vials). Prospective collections can be set up to support new research projects.
01

Capabilities mobilised

Therapeutic areasTherapeutic target discoveryValidation using preclinical modelsBiomarkersPlatforms
02

Application fields

Oncology

Discuss this offer

Could this capability strengthen your R&D programme?

Present your scientific, technical or clinical need and identify the most relevant route to collaboration.